NDC 63539-334 – Litfulo
Ritlecitinib Tosylate 50 mg/1 · Capsule · Oral
Product NDC63539-334
Product details
- Brand name
- Litfulo
- Generic name
- Ritlecitinib
- Labeler
- U.S. Pharmaceuticals
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- NDA · NDA215830
- Marketed since
- July 6, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Ritlecitinib Tosylate 50 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 63539-334-28 sample | 28 CAPSULE in 1 BOTTLE (63539-334-28) | Jul 6, 2023 |
Other Litfulo products
- 0069-0334 Ritlecitinib Tosylate 50 mg/1 · Capsule · Pfizer Laboratories Div Pfizer Inc